2 reports

R& D Progress Research and Development Brief Company reported that the drug candidate has demonstrated superior activity in tumors where PD-## monotherapy or PD-##/ LAG-## monoclonal antibody combo has shown activity.

  • Immunotherapy
  • Monoclonal Antibody
  • Research And Development
  • Therapy
  • MacroGenics, Inc.
  • Fate Therapeutics, Inc. - Research and Development Overview

Other Developmental Activities R& D Progress Research and Development Brief Licensing and Collaboration Product Description STEM CELL THERAPY ## FOR UNDISCLOSED INDICATION Stem cell therapy is under development for an undisclosed indication.

  • Research And Development
  • Therapy
  • United States
  • Company Operations
  • Fate Therapeutics, Inc.